Abu Ghanem Y - Search Results

1

[FOCAL TREATMENT OF PROSTATE CANCER - LEADING AND FUTURE TECHNIQUES, OUTCOMES AND COMPLICATIONS].

Orr Y, Zilberman DE, Abu Ghanem Y, Dotan ZA, Rosenzweig B. Orr Y, et al. Among authors: abu ghanem y. Harefuah. 2021 Sep;160(9):608-614. Harefuah. 2021. PMID: 34482675 Review. Hebrew.

2

Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.

Abu-Ghanem Y, Dotan Z, Kaver I, Ramon J. Abu-Ghanem Y, et al. J Surg Oncol. 2015 Oct;112(5):496-502. doi: 10.1002/jso.24029. Epub 2015 Oct 6. J Surg Oncol. 2015. PMID: 26437866

3

The use of Haemostatic Agents does not impact the rate of hemorrhagic complications in patients undergoing partial nephrectomy for renal masses.

Abu-Ghanem Y, Dotan Z, Kaver I, Zilberman DE, Ramon J. Abu-Ghanem Y, et al. Sci Rep. 2016 Aug 30;6:32376. doi: 10.1038/srep32376. Sci Rep. 2016. PMID: 27572274 Free PMC article.

4

Robot assisted laparoscopic radical prostatectomy: assistant's seniority has no influence on perioperative course.

Abu-Ghanem Y, Erlich T, Ramon J, Dotan Z, Zilberman DE. Abu-Ghanem Y, et al. J Robot Surg. 2017 Sep;11(3):305-309. doi: 10.1007/s11701-016-0655-z. Epub 2016 Nov 9. J Robot Surg. 2017. PMID: 27830431

5

Nephrolithiasis in Israel: Epidemiological Characteristics of Return Patients in a Tertiary Care Center.

Abu-Ghanem Y, Kleinmann N, Winkler HZ, Zilberman DE. Abu-Ghanem Y, et al. Isr Med Assoc J. 2016 Dec;18(12):725-728. Isr Med Assoc J. 2016. PMID: 28457074 Free article.

6

Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.

Abu-Ghanem Y, Zilberman DE, Dotan Z, Kaver I, Ramon J. Abu-Ghanem Y, et al. Urol Oncol. 2018 Jan;36(1):12.e15-12.e20. doi: 10.1016/j.urolonc.2017.09.006. Epub 2017 Oct 6. Urol Oncol. 2018. PMID: 28993059

7

Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.

Abu-Ghanem Y, Ramon J, Berger R, Kaver I, Fridman E, Leibowitz-Amit R, Dotan ZA. Abu-Ghanem Y, et al. World J Surg Oncol. 2017 Nov 2;15(1):193. doi: 10.1186/s12957-017-1257-6. World J Surg Oncol. 2017. PMID: 29096642 Free PMC article.

8

Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.

Shvero A, Nativ O, Abu-Ghanem Y, Zilberman D, Zaher B, Levitt M, Fridman E, Portnoy O, Ramon J, Dotan ZA. Shvero A, et al. Among authors: abu ghanem y. Clin Genitourin Cancer. 2018 Jun;16(3):e613-e617. doi: 10.1016/j.clgc.2017.10.016. Epub 2017 Nov 7. Clin Genitourin Cancer. 2018. PMID: 29174471

9

Retzius space reconstruction following transperitoneal laparoscopic robot-assisted radical prostatectomy: does it have any added value?

Abu-Ghanem Y, Dotan Z, Ramon J, Zilberman DE. Abu-Ghanem Y, et al. J Robot Surg. 2018 Sep;12(3):475-479. doi: 10.1007/s11701-017-0768-z. Epub 2017 Nov 27. J Robot Surg. 2018. PMID: 29181778

10

24-h urine metabolic profile: is it necessary in all kidney stone formers?

Abu-Ghanem Y, Shvero A, Kleinmann N, Winkler HZ, Zilberman DE. Abu-Ghanem Y, et al. Int Urol Nephrol. 2018 Jul;50(7):1243-1247. doi: 10.1007/s11255-018-1902-1. Epub 2018 Jun 6. Int Urol Nephrol. 2018. PMID: 29876775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page